| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Klaus F. Ley | Q89016809 |
| Philipp Von Hundelshausen | Q43094268 | ||
| P2093 | author name string | Christian A Gleissner | |
| P2860 | cites work | The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages | Q22253155 |
| Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils | Q24293111 | ||
| Induction of dendritic cell-like phenotype in macrophages during foam cell formation | Q24294246 | ||
| Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells | Q80217129 | ||
| Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells | Q80471129 | ||
| Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways | Q80736159 | ||
| Platelet factor 4 is chemotactic for neutrophils and monocytes | Q24302223 | ||
| An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 | Q24303828 | ||
| CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 | ||
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells | Q24323257 | ||
| Platelet-derived CXC chemokines: old players in new games | Q28141629 | ||
| The CC chemokines MDC and TARC induce platelet activation via CCR4 | Q28177034 | ||
| Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense | Q28186087 | ||
| Platelet alpha-granule proteins: studies on release and subcellular localization | Q28238444 | ||
| GRO family chemokines are specialized for monocyte arrest from flow | Q28254713 | ||
| Structural and functional comparison of the genes for human platelet factor 4 and PF4alt | Q28261701 | ||
| Occurrence of platelet basic protein, a precursor of low affinity platelet factor 4 and beta-thromboglobulin, in human platelets and megakaryocytes | Q28285768 | ||
| Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury | Q28286412 | ||
| Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets | Q28305812 | ||
| Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion | Q28578402 | ||
| Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. | Q28590391 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Chemokines: a new classification system and their role in immunity | Q29615663 | ||
| The biology of chemokines and their receptors | Q29619170 | ||
| Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines | Q29871535 | ||
| Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function | Q30306721 | ||
| Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. | Q30310323 | ||
| Role of platelets in the development of atherosclerosis | Q30312243 | ||
| Vascular adhesion molecules in atherosclerosis | Q30444182 | ||
| Laminar shear stress-induced GRO mRNA and protein expression in endothelial cells | Q31960227 | ||
| Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? | Q33341106 | ||
| Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications | Q33375217 | ||
| Response to injury and atherogenesis | Q33494262 | ||
| MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. | Q33844451 | ||
| The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation | Q33894356 | ||
| Megakaryocytes and beyond: the birth of platelets | Q34215516 | ||
| Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. | Q35088170 | ||
| Platelets and chemokines in atherosclerosis: partners in crime | Q36085380 | ||
| Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils | Q36357015 | ||
| Platelets as immune cells: bridging inflammation and cardiovascular disease | Q36699744 | ||
| CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms | Q40168375 | ||
| Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions | Q40420958 | ||
| Role of the platelet in atherogenesis | Q40796313 | ||
| Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner | Q42742789 | ||
| Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. | Q43511392 | ||
| Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells | Q44526949 | ||
| Platelet factor 4 (PF-4)–induced neutrophil adhesion is controlled by src-kinases, whereas PF-4–mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase | Q44639015 | ||
| Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients | Q44987493 | ||
| Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease | Q46745405 | ||
| Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals | Q46802145 | ||
| Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G. | Q46827240 | ||
| Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
| Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis. | Q51606009 | ||
| CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3. | Q51792193 | ||
| Requirement for CD154 in the progression of atherosclerosis. | Q52536870 | ||
| Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface. | Q52545982 | ||
| Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. | Q53522261 | ||
| Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. | Q53999657 | ||
| RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. | Q54014329 | ||
| Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium | Q57574602 | ||
| Dynamic Visualization of Thrombopoiesis Within Bone Marrow | Q58450371 | ||
| MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions | Q59064735 | ||
| Regulation of endothelial progenitor cell homing after arterial injury | Q61612305 | ||
| CXCR3-mediated opposite effects of CXCL10 and CXCL4 on T1 or T2 cytokine production | Q61638171 | ||
| Platelet-derived chemokines in vascular biology | Q63916907 | ||
| The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. | Q64928622 | ||
| Release of platelet factor 4 in vivo during intravascular coagulation and in thrombotic states | Q68428788 | ||
| Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis | Q70660633 | ||
| TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines | Q70988422 | ||
| Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta | Q71656917 | ||
| Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways. Discrepancies in binding affinities, receptor densities, and biologic effects | Q72303938 | ||
| Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2 | Q72879713 | ||
| The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2 | Q73886945 | ||
| Human vascular smooth muscle cells express receptors for CC chemokines | Q74351441 | ||
| Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells | Q74410090 | ||
| Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration | Q74650583 | ||
| Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells | Q77319716 | ||
| Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice | Q77340592 | ||
| Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4 | Q77353640 | ||
| Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action | Q78039757 | ||
| Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells | Q79086335 | ||
| Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters | Q79339926 | ||
| Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice | Q79828506 | ||
| Genetic control of chemokines in severe human internal carotid artery stenosis | Q80149834 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1920-1927 | |
| P577 | publication date | 2008-08-21 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Platelet chemokines in vascular disease | |
| P478 | volume | 28 |
| Q34002877 | Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells |
| Q27677101 | Alternative C-Terminal Helix Orientation Alters Chemokine Function: STRUCTURE OF THE ANTI-ANGIOGENIC CHEMOKINE, CXCL4L1 |
| Q42690438 | An In Vitro Investigation of Platelet-Rich Plasma-Gel as a Cell and Growth Factor Delivery Vehicle for Tissue Engineering |
| Q38828527 | Apoptotic and anti-angiogenic effects of Salvia triloba extract in prostate cancer cell lines |
| Q38390385 | Bacteria-induced intracellular signalling in platelets |
| Q33401507 | Bidirectional crosstalk between platelets and monocytes initiated by Toll-like receptor: an important step in the early defense against fungal infections? |
| Q43159403 | CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis |
| Q41859211 | CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages |
| Q36239789 | CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology |
| Q36187349 | CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. |
| Q30433527 | CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages |
| Q98183379 | Cancer animal models in thrombosis research |
| Q35483514 | Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome |
| Q38479492 | Changes in transcriptome of macrophages in atherosclerosis |
| Q90478647 | Chemokine Receptor 5, a Double-Edged Sword in Metabolic Syndrome and Cardiovascular Disease |
| Q34672038 | Chemokine receptor CCR5: from AIDS to atherosclerosis |
| Q34532189 | Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression |
| Q26861509 | Contribution of blood platelets to vascular pathology in Alzheimer's disease |
| Q33402947 | Coronary artery remodeling in a model of left ventricular pressure overload is influenced by platelets and inflammatory cells |
| Q33493041 | Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patients |
| Q35091837 | Cytokine network in scrub typhus: high levels of interleukin-8 are associated with disease severity and mortality |
| Q30495417 | Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators |
| Q64100339 | Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review |
| Q93382031 | Extra virgin olive oil: More than a healthy fat |
| Q57315819 | Gene expression signatures, pathways and networks in carotid atherosclerosis |
| Q42276947 | Genetic variants in Arhgef11 are associated with kidney injury in the Dahl salt-sensitive rat. |
| Q37738343 | Genetics of atherothrombosis and thrombophilia |
| Q34902005 | Genome-wide association studies in atherosclerosis |
| Q36711718 | Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis |
| Q48005977 | Growth-promoting action and growth factor release by different platelet derivatives. |
| Q55109334 | High-resolution Imaging of Myeloperoxidase Activity Sensors in Human Cerebrovascular Disease. |
| Q38608338 | How leukocytes cross the vascular endothelium |
| Q37681981 | Hyperglycemia enhances arsenic-induced platelet and megakaryocyte activation |
| Q53086984 | Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease. |
| Q36023157 | Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque |
| Q35690758 | Involvement of Visceral Adipose Tissue in Immunological Modulation of Inflammatory Cascade in Preeclampsia |
| Q97545559 | Longitudinal Cytokine Profiling Identifies GRO-α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia |
| Q37978620 | Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis |
| Q38260570 | Macrophage phenotypes in atherosclerosis. |
| Q42472707 | Markers of Blood Cell Activation and Complement Activation in Factor VIII and von Willebrand Factor Concentrates |
| Q58701086 | Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver |
| Q28552772 | Microdialysis Sampling from Wound Fluids Enables Quantitative Assessment of Cytokines, Proteins, and Metabolites Reveals Bone Defect-Specific Molecular Profiles |
| Q27339951 | Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis |
| Q34153125 | Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation |
| Q42433273 | Neutrophils in atherosclerosis: alarmin evidence of a hit and run? |
| Q33576883 | PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease |
| Q91281532 | Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice |
| Q30412717 | Phenotypic polarization of macrophages in atherosclerosis |
| Q34294091 | Plasma cytokine concentrations indicate that in vivo hormonal regulation of immunity is altered during long-duration spaceflight |
| Q34333912 | Plasmodium coatneyi in rhesus macaques replicates the multisystemic dysfunction of severe malaria in humans |
| Q30410705 | Plasmodium falciparum infection induces expression of a mosquito salivary protein (Agaphelin) that targets neutrophil function and inhibits thrombosis without impairing hemostasis |
| Q39449769 | Platelet "first responders" in wound response, cancer, and metastasis |
| Q30497499 | Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis |
| Q36121474 | Platelet Supernatant Suppresses LPS-Induced Nitric Oxide Production from Macrophages Accompanied by Inhibition of NF-κB Signaling and Increased Arginase-1 Expression. |
| Q48242661 | Platelet activation in chronic cocaine users: effect of short term abstinence |
| Q37487079 | Platelet alpha-granules: basic biology and clinical correlates |
| Q99581595 | Platelet factor 4 inhibits human hair follicle growth and promotes androgen receptor expression in human dermal papilla cells |
| Q40946825 | Platelet secretion of CXCL4 is Rac1-dependent and regulates neutrophil infiltration and tissue damage in septic lung damage |
| Q38281989 | Platelet secretion: From haemostasis to wound healing and beyond |
| Q42371900 | Platelet-Derived Chemokine CXCL7 Dimer Preferentially Exists in the Glycosaminoglycan-Bound Form: Implications for Neutrophil-Platelet Crosstalk |
| Q50257338 | Platelet-Specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury. |
| Q27329947 | Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7 |
| Q36950818 | Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration |
| Q35779411 | Platelet-neutrophil interactions under thromboinflammatory conditions |
| Q55279252 | Platelets Promote Brucella abortus Monocyte Invasion by Establishing Complexes With Monocytes. |
| Q90293465 | Platelets and Complement Cross-Talk in Early Atherogenesis |
| Q42324464 | Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). |
| Q34294719 | Platelets and cancer: a casual or causal relationship: revisited. |
| Q39125083 | Platelets and von Willebrand factor in atherogenesis |
| Q33432917 | Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond |
| Q38160535 | Platelets as immune cells in infectious diseases. |
| Q33427709 | Platelets attenuate production of cytokines and nitric oxide by macrophages in response to bacterial endotoxin |
| Q34002250 | Platelets guide the formation of early metastatic niches |
| Q38364980 | Platelets in leucocyte recruitment and function |
| Q92650591 | Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy |
| Q37970013 | Platelets: a critical link between inflammation and microvascular dysfunction |
| Q39248498 | Platelets: much more than bricks in a breached wall. |
| Q38504066 | Proteomic characterization of human early pro-angiogenic cells |
| Q38430645 | Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets |
| Q59791517 | Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation |
| Q28393808 | Role of platelets in neuroinflammation: a wide-angle perspective |
| Q34993353 | Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages. |
| Q42170536 | SDF-1α is a novel autocrine activator of platelets operating through its receptor CXCR4. |
| Q90181215 | Sex Differences in Circulating Biomarkers of Cardiovascular Disease |
| Q90511412 | Start a fire, kill the bug: The role of platelets in inflammation and infection |
| Q36600107 | Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen |
| Q54569157 | Streptococcus sanguinis-induced cytokine release from platelets. |
| Q38785881 | Taking the stock of granule cargo: Platelet releasate proteomics |
| Q61811076 | The Multitasking Potential of Alarmins and Atypical Chemokines |
| Q57812382 | The Role of Chemokines in Wound Healing |
| Q50494182 | The effect of pre-storage whole-blood leukocyte reduction on cytokines/chemokines levels in autologous CPDA-1 whole blood. |
| Q38367124 | The expanding field of platelet-bacterial interconnections |
| Q37798968 | The role of calpain in diabetes-associated platelet hyperactivation. |
| Q88671029 | The role of platelets in acute kidney injury |
| Q28246124 | Thrombin and vascular inflammation |
| Q38951112 | Time course of cardiac inflammation during nitric oxide synthase inhibition in SHR: impact of prior transient ACE inhibition |
| Q36641448 | Transcriptomic analysis of the stress response to weaning at housing in bovine leukocytes using RNA-seq technology |
| Q92257481 | Vascularized Microfluidics and the Blood-Endothelium Interface |
Search more.